|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/444 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/553 | (2013.01) | ||
| A61K 31/53 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/551 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/365 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61K 31/404 | (2006.01) | ||
| A61K 31/404 | (2013.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/44 | (2013.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61K 31/4709 | (2013.01) | ||
| A61K 31/4709 | (2006.01) | ||
| A61K 31/444 | (2013.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/365 | (2013.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61K 31/497 | (2013.01) | ||
| A61K 31/5025 | (2006.01) | ||
| A61K 31/5025 | (2013.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/437 | (2013.01) | ||
| A61K 31/553 | (2006.01) | ||
| C07D 251/52 | (2013.01) | ||
| C07D 403/14 | (2013.01) | ||
| C07D 401/14 | (2013.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 3419594 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16819389.4 |
| Date of filing the European patent application | 2016-12-02 | |
| (97) | Date of publication of the European application | 2019-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/064845 |
| Date | 2016-12-02 |
| (87) | Number | WO 2017/146795 |
| Date | 2017-08-31 |
| (30) | Number | Date | Country code |
| 201662300673 P | 2016-02-26 | US |
| (72) |
CHOE, Sung, Eun , US
WU, Bin , US
AMATANGELO, Michael , US
HU, Xiaolan , US
THAKURTA, Anjan , US
|
| (73) |
Les Laboratoires Servier ,
50 rue Carnot, 92284 Suresnes Cedex,
FR
Celgene Corporation , 86 Morris Avenue, Summit, NJ 07901, US |
| (54) | IVOSIDENIB FOR USE IN THE TREATMENT OF RELAPSED/REFRACTORY AML |
| IVOSIDENIB FOR USE IN THE TREATMENT OF RELAPSED/REFRACTORY AML |